Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1984-12-14
|
pubmed:abstractText |
Antithrombin III (AT-III) deficiency has been associated with increased risk of venous and arterial thromboses and arterial graft failure. Deficiency of this circulating glycoprotein may be congenital; however, acquired deficiencies may develop in protein-losing or protein-wasting states. In the present study, AT-III levels of 108 patients undergoing vascular surgical procedures were determined preoperatively and at intervals (third, fifth, and seventh days) postoperatively. The mean AT-III level was then compared to the patient's protein status. The effect of reduced AT-III activity on early graft failure was also noted. A low preoperative AT-III level (less than 80%) was found in 16.3% of the patients studied. Among 83 patients with serum albumin levels greater than 3.0 gm/dl or transferrin levels greater than 180 mg/dl, reduced AT-III activity was present in only 10 (12%). In contrast, when serum albumin levels were less than 3.0 gm/dl, AT-III deficiency was found in 12 of 25 patients (48%) (p less than 0.01). Early thrombosis of a femorodistal graft occurred in 5 of 15 patients (33%) with reduced AT-III levels. When AT-III levels were normal, early bypass failure occurred in only 9 of 67 grafts (13.4%). However, this difference was not statistically significant. An additional 15 patients had sequential pre- and postoperative measurements (up to 3 weeks) of serum protein and AT-III levels to illustrate the relationship between the dynamics of protein metabolism and AT-III levels. There was a clear temporal relationship between albumin, transferrin, and AT-III levels.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0741-5214
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
888-95
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:6492312-Aged,
pubmed-meshheading:6492312-Antithrombin III,
pubmed-meshheading:6492312-Antithrombin III Deficiency,
pubmed-meshheading:6492312-Blood Proteins,
pubmed-meshheading:6492312-Female,
pubmed-meshheading:6492312-Humans,
pubmed-meshheading:6492312-Male,
pubmed-meshheading:6492312-Nutritional Physiological Phenomena,
pubmed-meshheading:6492312-Postoperative Care,
pubmed-meshheading:6492312-Postoperative Complications,
pubmed-meshheading:6492312-Postoperative Period,
pubmed-meshheading:6492312-Risk,
pubmed-meshheading:6492312-Serum Albumin,
pubmed-meshheading:6492312-Thrombosis,
pubmed-meshheading:6492312-Transferrin,
pubmed-meshheading:6492312-Vascular Surgical Procedures
|
pubmed:year |
1984
|
pubmed:articleTitle |
Antithrombin III deficiency as a reflection of dynamic protein metabolism in patients undergoing vascular reconstruction.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|